Shandong Pharmaceutical GlassLtd Future Growth
Future criteria checks 1/6
Shandong Pharmaceutical GlassLtd is forecast to grow earnings and revenue by 17.4% and 12.8% per annum respectively. EPS is expected to grow by 17.4% per annum. Return on equity is forecast to be 13.1% in 3 years.
Key information
17.4%
Earnings growth rate
17.4%
EPS growth rate
| Medical Equipment earnings growth | 23.9% |
| Revenue growth rate | 12.8% |
| Future return on equity | 13.1% |
| Analyst coverage | Good |
| Last updated | 25 Apr 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 7,073 | 1,353 | N/A | 1,610 | 4 |
| 12/31/2025 | 6,493 | 1,169 | N/A | 1,357 | 8 |
| 12/31/2024 | 5,645 | 995 | N/A | 1,050 | 7 |
| 3/31/2024 | 5,013 | 830 | 459 | 1,134 | N/A |
| 12/31/2023 | 4,982 | 776 | 376 | 1,048 | N/A |
| 9/30/2023 | 4,872 | 738 | 82 | 781 | N/A |
| 3/31/2023 | 4,382 | 632 | -99 | 502 | N/A |
| 12/31/2022 | 4,187 | 618 | -458 | 252 | N/A |
| 9/30/2022 | 4,058 | 616 | -277 | 548 | N/A |
| 6/30/2022 | 4,040 | 612 | -112 | 674 | N/A |
| 3/31/2022 | 3,991 | 588 | 25 | 773 | N/A |
| 12/31/2021 | 3,875 | 591 | -59 | 750 | N/A |
| 9/30/2021 | 3,921 | 620 | -55 | 676 | N/A |
| 6/30/2021 | 3,703 | 603 | -206 | 551 | N/A |
| 3/31/2021 | 3,592 | 585 | -243 | 445 | N/A |
| 12/31/2020 | 3,427 | 564 | 31 | 566 | N/A |
| 9/30/2020 | 3,147 | 532 | -6 | 498 | N/A |
| 6/30/2020 | 3,093 | 503 | 89 | 594 | N/A |
| 3/31/2020 | 3,042 | 484 | -53 | 596 | N/A |
| 12/31/2019 | 2,992 | 459 | 7 | 599 | N/A |
| 9/30/2019 | 2,821 | 437 | -87 | 546 | N/A |
| 6/30/2019 | 2,720 | 409 | -31 | 493 | N/A |
| 3/31/2019 | 2,651 | 386 | 124 | 492 | N/A |
| 12/31/2018 | 2,585 | 358 | 118 | 466 | N/A |
| 9/30/2018 | 2,546 | 326 | 245 | 485 | N/A |
| 6/30/2018 | 2,481 | 298 | 237 | 446 | N/A |
| 3/31/2018 | 2,400 | 281 | 187 | 349 | N/A |
| 12/31/2017 | 2,330 | 263 | N/A | 412 | N/A |
| 9/30/2017 | 2,314 | 259 | N/A | 349 | N/A |
| 6/30/2017 | 2,236 | 236 | N/A | 423 | N/A |
| 3/31/2017 | 2,181 | 216 | N/A | 461 | N/A |
| 12/31/2016 | 2,057 | 190 | N/A | 507 | N/A |
| 9/30/2016 | 1,860 | 162 | N/A | 478 | N/A |
| 6/30/2016 | 1,801 | 159 | N/A | 446 | N/A |
| 3/31/2016 | 1,758 | 152 | N/A | 465 | N/A |
| 12/31/2015 | 1,723 | 145 | N/A | 390 | N/A |
| 9/30/2015 | 1,771 | 141 | N/A | 440 | N/A |
| 6/30/2015 | 1,771 | 130 | N/A | 341 | N/A |
| 3/31/2015 | 1,717 | 127 | N/A | 293 | N/A |
| 12/31/2014 | 1,691 | 125 | N/A | 267 | N/A |
| 9/30/2014 | 1,653 | 117 | N/A | 282 | N/A |
| 6/30/2014 | 1,599 | 122 | N/A | 260 | N/A |
| 3/31/2014 | 1,577 | 121 | N/A | 286 | N/A |
| 12/31/2013 | 1,545 | 122 | N/A | 269 | N/A |
| 9/30/2013 | 1,519 | 126 | N/A | 164 | N/A |
| 6/30/2013 | 1,514 | 124 | N/A | 188 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600529's forecast earnings growth (17.4% per year) is above the savings rate (2.9%).
Earnings vs Market: 600529's earnings (17.4% per year) are forecast to grow slower than the CN market (24.3% per year).
High Growth Earnings: 600529's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600529's revenue (12.8% per year) is forecast to grow slower than the CN market (14.6% per year).
High Growth Revenue: 600529's revenue (12.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600529's Return on Equity is forecast to be low in 3 years time (13.1%).